FAM186A Inhibitors
Chemical inhibitors of FAM186A operate through diverse molecular mechanisms to inhibit its function within cellular processes. Paclitaxel, for instance, exerts its inhibitory effect by stabilizing microtubules and preventing their disassembly, which is crucial for maintaining cellular structures and facilitating intracellular transport. This action can directly affect cellular processes essential for FAM186A function, such as cell division or intracellular trafficking. Similarly, Mitoxantrone and Camptothecin disrupt DNA replication and transcription through intercalation and topoisomerase inhibition, respectively. Mitoxantrone interferes with topoisomerase II while Camptothecin targets topoisomerase I, both leading to DNA damage and cell cycle arrest, which can inhibit the function of FAM186A in cell proliferation.
Other inhibitors, such as Bortezomib, Rapamycin, and Trichostatin A, impact cellular regulatory pathways that influence FAM186A functionality. Bortezomib impedes the proteasomal degradation pathway, leading to an accumulation of proteins that may disturb cellular homeostasis and the degradation processes involving FAM186A. Rapamycin, through its interaction with FKBP12, inhibits the mTOR pathway, a central regulator of cell growth and proliferation, thus potentially downregulating FAM186A-related processes. Trichostatin A inhibits histone deacetylases, affecting gene expression and inducing cell cycle arrest, which could hinder the epigenetic regulation of genes where FAM186A is active. Erlotinib and WZ8040, both EGFR inhibitors, disrupt signaling pathways crucial for cell proliferation, thereby impairing the cellular context in which FAM186A operates. Sorafenib targets multiple kinases within the RAF/MEK/ERK pathway, affecting angiogenesis and cell proliferation, which are processes where FAM186A may play a role. Lastly, ZM447439 disrupts chromosome alignment during mitosis by inhibiting Aurora kinases, potentially impeding cell cycle progression where FAM186A is implicated. Each of these chemical inhibitors, through their unique modes of action, can contribute to the functional inhibition of FAM186A within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and prevents their disassembly, which can inhibit cellular processes essential for FAM186A function, such as intracellular transport or cell division, leading to the functional inhibition of FAM186A. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone intercalates into DNA and inhibits topoisomerase II, disrupting DNA replication and transcription. This action can inhibit the cellular proliferation necessary for the expression and function of FAM186A in rapidly dividing cells. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits topoisomerase I, leading to DNA damage and the inhibition of DNA replication and transcription. This causes cell cycle arrest, which can functionally inhibit the role of FAM186A in cell proliferation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib inhibits the 26S proteasome, leading to the accumulation of polyubiquitinated proteins and disruption of cellular homeostasis. This can inhibit the degradation pathways in which FAM186A may be involved, leading to its functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to FKBP12 and inhibits mTOR, which is crucial for cell growth and proliferation. This inhibition can downregulate processes that are necessary for FAM186A's function in cell growth. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporine A binds to cyclophilins and inhibits calcineurin, thereby inhibiting T-cell activation and IL-2 production. This immunosuppressive effect can indirectly inhibit FAM186A by reducing the proliferative signals that may regulate its function. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine raises intracellular pH by accumulating in lysosomes, impairing lysosomal enzyme activity and autophagy. This can functionally inhibit FAM186A by disrupting the cellular recycling processes it may be involved in. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib inhibits epidermal growth factor receptor (EGFR) tyrosine kinase, interrupting signaling pathways that promote cell proliferation. Such inhibition can impede the cellular context in which FAM186A operates, thereby inhibiting its function. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a multikinase inhibitor that blocks the RAF/MEK/ERK pathway, which can inhibit angiogenesis and cell proliferation. Inhibiting this pathway can functionally inhibit FAM186A by impairing the signaling that may be necessary for its activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases (HDAC), which can alter gene expression and induce cell cycle arrest. This can functionally inhibit FAM186A by disrupting the epigenetic regulation of cell cycle-related genes where FAM186A may play a role. | ||||||